Case Reports in Endocrinology
Volume 2021 (2021), Article ID 7320217, 1 page
https://doi.org/10.1155/2021/7320217

Corrigendum

Corrigendum to “A Case of Severe Acute Kidney Injury Exacerbated by Canagliflozin in a Patient with Type 2 Diabetes”

Kimya Hassani-Ardakani,¹ Mark L. Lipman,² Denny Laporta,³ and Oriana Hoi Yun Yu4,5

¹Department of Medicine, Jewish General Hospital, McGill University, Montreal H3T 1E2, Canada
²Division of Nephrology, Department of Medicine, Jewish General Hospital, Montreal H3T 1E2, Canada
³Division of Adult Critical Care, Department of Medicine, Jewish General Hospital, Montreal H3T 1E2, Canada
⁴Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal H3T 1E2, Canada
⁵Division of Endocrinology, Department of Medicine, Jewish General Hospital, Montreal H3T 1E2, Canada

Correspondence should be addressed to Oriana Hoi Yun Yu; hoi.yu@mcgill.ca

Received 25 January 2021; Accepted 25 January 2021; Published 8 February 2021

Copyright © 2021 Kimya Hassani-Ardakani et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

In the article titled “A Case of Severe Acute Kidney Injury Exacerbated by Canagliflozin in a Patient with Type 2 Diabetes” [1], there was a spelling error in the author Kimya Hassani-Ardakani’s name in the author list, where Kimya Hassani-Ardakania should have read Kimya Hassani-Ardakani. This is corrected as shown above.

References

K. Hassani-Ardakani, M. L. Lipman, D. Laporta, and O. H. Yun Yu, “A Case of Severe Acute Kidney Injury Exacerbated by Canagliflozin in a Patient with Type 2 Diabetes,” Case Reports in Endocrinology, vol. 2019, Article ID 8639629, 4 pages, 2019.